NCT00191815 - Combination Chemotherapy for Metastatic Breast Cancer | Biotech Hunter

Enrollment

70

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

October 31, 2007

Conditions

Breast Cancer

Interventions

DRUG

Gemcitabine

Gemcitabine (30 min intravenous infusion) dose of 1000mg/m2 on Day 1 and Day 8 (21 day cycle).

DRUG

cisplatin

Cisplatin (30-120 min intravenous infusion) dose of 35 mg/m2 on Day 1 and Day 8 (21 day cycle).

Trial Locations (2)

81377

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9AM to 5PM Eastern time (UTC/ GMT - 5hours, EST), or speak with your personal physician, Munich

115478

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9AM to 5PM Eastern time (UTC/ GMT - 5hours, EST), or speak with your personal physician, Moscow